Lemon Crush CLIQ

We’ve got a pretty big crush on these buds! Lemon Crush is a beautiful, bold, and balanced hybrid strain of cannabis, resulting from a cross of Skunk #1 and Northern Lights. It exudes strong aromas of citrus, cream, and herbs that stimulate and elate. Cannasseurs who prefer this cut gravitate toward its potential aid in mood, drive, and creativity.

Select Cliq provides patients with new vape pod technology that preserves the integrity of cannabis oil with a contoured pod well and ceramic core heating element. Each pod features 0.5 g or 1g of premium cannabis oil and cannabis terpenes. Cliq pods deliver medication via inhalation. Select holds their oil to the highest standards with the most stringent & progressive testing in the industry. They were the first company to begin proactively testing for a full panel of 66 analytes at the PPB (Parts Per Billion) level. Select uses Ethanol Hash Oil extraction methods, allowing for the greatest levels of cannabinoid retention. Select's thoughtful terpene preservation process delivers an unmatched oil, superior in quality & potency. The strain of marijuana from which it was extracted, cannabidiol content, tetrahydrocannabinol content will vary by harvest. Inhalation is a fast-acting method of administration, with a typical onset of effect within 90 seconds. THCA content varies by harvest. This product must be stored and transported in its original packaging to comply with Florida law.

Vaporization delivers cannabinoids in a manner that can be easily titrated to the desired result. Cliq pods are best used with a Cliq Variable Battery (2.8V, 3.2V, 3.6V), included in Cliq Pod Kit or separately. The average dose for this product is 5mg, two times per day.

Cost is based on average dosing for this product:

30-day supply is $48

50-day supply is $80

70-day supply is $112

Patients must consult a certified physician to obtain the dose that works best based on their medical condition. 30, 50, 70-day supply cost is based on average doses and may not apply to all patients.